ArticleBMC infectious diseases2026
Machine learning-based precision subtyping and risk prediction in sepsis: a retrospective analysis using MIMIC-IV database.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPrecise subtyping is crucial for enabling personalized treatments in sepsis patients. This study aims to develop an analytical framework for sepsis intervention, integrating variable selection and phenotype discovery for diverse settings.
methodsUsing MIMIC-IV database, study included sepsis patients (ICD-9/10 codes), excluding those with < 24-hour stay or missing data. Data included demographics, labs, comorbidities, and follow-up status. The primary endpoint was 90-day all-cause mortality.First, variables significantly associated with 90-day mortality were preliminarily screened using multivariate Cox regression analysis.Subsequently, the optimal machine learning model was selected based on the C-index evaluation, and this model was used to further identify core factors from the preliminarily screened variables. Finally, patients were subgrouped using K-means clustering based on the characteristics of the core factors, and the subgroups were validated through baseline and survival analyses.The optimal number of clusters (K value) was determined using both the elbow method and the gap statistic.
results6,086 patients included (90-day mortality 23.87%). Cox regression identified 24 independent predictors (all p < 0.001), and a high-performance Ridge risk prediction model was developed (average C-index = 0.761). Multidimensional clustering based on 9 core variables(|coefficient|>0.1) revealed distinct subtypes (K = 4, 8,14, respectively). Increasing cluster granularity (K from 4 to 14) revealed converging characteristics across subgroups but refined risk stratification. Current ICU admission was identified as a key protective factor, while past ICU history, high age, poor cardiopulmonary function, hypermagnesemia, and PTT/RDW abnormalities were the three core high-risk drivers. The low-risk group (younger age+current ICU admission + no ICU history+better cardiopulmonary function) had a lowest mortality rate of 9.7% in 4-subtype system and 3.4% in the 14-subtype system. Patients without current ICU protection or with the other risk factors showed higher mortality risk than the low-risk group. Notably, extremely high level of RDW (21.6%, subgroup 14, mortality rate 45.42%) and PTT values (130.35s, subgroup 10, mortality rate 33.78%) were independent of age and cardiopulmonary issues, suggesting they define two distinct high-risk subtypes.
conclusionsThis study developed a clinically universal and interpretable sepsis subtyping framework using routine clinical variables, identifying subgroups with significant mortality differences, providing a pragmatic tool for risk stratification and prognosis assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.